More recent reports have shown that inhibition of BCL-XL by an orally available ABT-737-derivative, ABT-263 (navitoclax), and MCL-1 by A-1210477 enhances apoptosis in HNSCC cells [46]. The gene discussed is MCL1; the disease is head and neck squamous cell carcinoma.